{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:58:03Z","timestamp":1791417483092,"version":"4.3.3"},"update-to":[{"DOI":"10.1002\/14651858.cd004692.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T00:00:00Z","timestamp":1446595200000}}],"reference-count":190,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004692.pub4","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T11:59:49Z","timestamp":1446724789000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Omega-3 fatty acids for depression in adults"],"prefix":"10.1002","author":[{"given":"Katherine M","family":"Appleton","sequence":"first","affiliation":[{"name":"Bournemouth University; Department of Psychology; Poole House, Fern Barrow Poole UK BH12 5BB"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M","family":"Sallis","sequence":"additional","affiliation":[{"name":"University of Bristol; Centre for Academic Mental Health, School of Social and Community Medicine; Barley House Oakfield Grove Bristol UK BS8 2BN"},{"name":"University of Bristol; MRC Integrative Epidemiology Unit, School of Social and Community Medicine; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Perry","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol Education Centre; NIHR Biomedical Research Unit in Nutrition, Diet and Lifestyle; Upper Maudlin Street Bristol Avon UK BS2 8AE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Ness","sequence":"additional","affiliation":[{"name":"University Hospitals Bristol NHS Foundation Trust and the University of Bristol; National Institute for Health Research (NIHR) Biomedical Research Unit in Nutrition, Diet and Lifestyle; Upper Maudlin Street Bristol Avon UK BS2 8AE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[{"name":"University of Bristol; Centre for Academic Mental Health, School of Social and Community Medicine; Barley House Oakfield Grove Bristol UK BS8 2BN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,11,4]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000321804","article-title":"Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: A randomized controlled pilot study","volume":"63","author":"Bot","year":"2011","journal-title":"Neuropsychobiology"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub4-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jad.2010.04.008","article-title":"Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study [ISRCTN30877831; NTR624]","volume":"126","author":"Bot","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e49431","DOI":"10.1371\/journal.pone.0049431","article-title":"Biological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial","volume":"7","author":"Mocking","year":"2012","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0004|cit4","unstructured":"Pouwer F Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study www.controlled-trials.com\/ISRCTN30877831"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub4-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.NT.0000303363.61251.8f","article-title":"News breaks","volume":"44","author":"Anonymous","year":"2009","journal-title":"Nutrition Today"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub4-BIB0006|cit6","first-page":"523","article-title":"Use of omega-3 with treatment for depression in heart disease patients may not provide benefit","volume":"7","author":"Anonymous","year":"2009","journal-title":"Nurse Prescribing"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpsychores.2010.11.006","article-title":"Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression","volume":"71","author":"Bot","year":"2011","journal-title":"Journal of Psychosomatic Research"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0010|cit8","unstructured":"Carney RM Omega-3 fatty acids to improve depression and reduce cardiovascular risk factors ClinicalTrials.gov\/show\/NCT00116857"},{"issue":"15","key":"10.1002\/14651858.CD004692.pub4-BIB0008|cit9","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2009.1487","article-title":"Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: A randomized controlled trial [NCT00116857]","volume":"302","author":"Carney","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub4-BIB0009|cit10","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2010.191","article-title":"'Omega-3 fatty acids for CHD with depression': Reply to comment","volume":"303","author":"Carney","year":"2010","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1753-4887.2009.00263.x","article-title":"Nutrition updates","volume":"68","author":"D'Anci","year":"2010","journal-title":"Nutrition Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.10m06455","article-title":"Obstructive sleep apnea\/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease","volume":"73","author":"Roest","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0013|cit13","unstructured":"Coryell WH Essential fatty acids for major depression ClinicalTrials.gov\/show\/NCT00256412"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0014|cit14","first-page":"157","article-title":"Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram","volume":"22","author":"Fiedorowicz","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0015|cit15","unstructured":"Coryell WH Essential fatty acids for major depression ClinicalTrials.gov\/show\/NCT00256412"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0016|cit16","first-page":"157","article-title":"Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram","volume":"22","author":"Fiedorowicz","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub4-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"Silva","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub4-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"Silva","year":"2008","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0020|cit19","unstructured":"Gertsik L PUFA augmentation in treatment of major depression ClinicalTrials.gov\/show\/NCT00067301"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0019|cit20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/JCP.0b013e31823f3b5f","article-title":"Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder","volume":"32","author":"Gertsik","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MJT.0000000000000078","article-title":"Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients","volume":"21","author":"Dashti-Khavidaki","year":"2014","journal-title":"American Journal of Therapeutics"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub4-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00228-014-1666-1","article-title":"The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: A randomized, placebo-controlled clinical trial","volume":"70","author":"Gharekhani","year":"2014","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2008-2231-22-11","article-title":"Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients","volume":"22","author":"Gharekhani","year":"2014","journal-title":"DARU"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0024|cit24","unstructured":"Khatami MR Evaluating therapeutic effects of omega-3 fatty acids on anemia and nutritional status in hemodialysis patients with depression www.irct.ir\/searchresult.php?id=3043&number=5"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0025|cit25","first-page":"72","article-title":"Omega-3 fatty acids as adjunctive of antidepressant therapy and its effects on brain-derived neurotrophic factor in serum, monocytes and lymphocytes","volume":"30","author":"Gonzalez","year":"2011","journal-title":"Archivos Venezolanos de Farmacologia y Terapeutica"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.pnpbp.2007.06.004","article-title":"Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial","volume":"31","author":"Grenyer","year":"2007","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11745-013-3801-7","article-title":"Improvement of major depression is associated with increased erythrocyte DHA","volume":"48","author":"Meyer","year":"2013","journal-title":"Lipids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0028|cit28","first-page":"30","article-title":"Fish oil not effective for chronic refractory depression","volume":"13","author":"Rotblatt","year":"2008","journal-title":"Focus on Alternative & Complementary Therapies"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","article-title":"Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder","volume":"178","author":"Jazayeri","year":"2010","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","article-title":"Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder","volume":"178","author":"Jazayeri","year":"2010","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0034|cit33","unstructured":"Lesp\u00e9rance F Double-blind, placebo-controlled, randomised trial of eicosapentaenoic acid (EPA) for major depression www.controlled-trials.com\/ISRCTN47431149\/"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub4-BIB0033|cit34","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.10m05966blu","article-title":"The efficacy of omega-3 supplementation for major depression: A randomized controlled trial [ISRCTN47431149]","volume":"72","author":"Lesp\u00e9rance","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0036|cit35","unstructured":"Lucas M Double-blind, placebo-controlled, randomised, clinical trial of eicosapentaenoic acid in the treatment of mood disorders among middle-aged women www.controlled-trials.com\/ISRCTN69617477"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0035|cit36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3945\/ajcn.2008.26749","article-title":"Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial","volume":"89","author":"Lucas","year":"2009","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0038|cit38","unstructured":"Marangell LB Zboyan HA Cress KK Benisek D Arterburn L A double-blind, placebo-controlled study of docosahexaenoic acid (DHA) in the treatment of depression 4th Congress of the International Society for the Study of Lipids and Fatty Acids, Tsukuba, Japan"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0041|cit39","unstructured":"Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00361374"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0039|cit40","unstructured":"Mischoulon D Nierenberg AA Schettler PJ Kinkead B Fehling K Martinson M Clinical predictors of response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16;Toronto, ON Canada] 2015 147S"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0040|cit41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4088\/JCP.14m08986","article-title":"A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression","volume":"76","author":"Mischoulon","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0045|cit42","unstructured":"Rapaport MH Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16; Toronto, ON Canada] 2015 146S 7S"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0042|cit43","unstructured":"Rapaport MH Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00517036"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0043|cit44","unstructured":"Rapaport MH Nierenberg AA Schettler PJ Kinkead B Cardoos A Walker R Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study Molecular Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0044|cit45","unstructured":"Rapaport MH Schettler P Pace TW Kinkead B Nierenberg AA Mischoulon D Inflammation, depression and N-3 fatty acids: A case of personalized medicine abstract Neuropsychopharmacology [abstracts of the 52nd Annual Meeting of the American College of Neuropsychopharmacology, ACNP; 2013 Dec 8 - 12; Hollywood, FL United States] 2013 S353 S4"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0048|cit46","unstructured":"Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00361374"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0046|cit47","unstructured":"Mischoulon D Nierenberg AA Schettler PJ Kinkead B Fehling K Martinson M Clinical predictors of response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16;Toronto, ON Canada] 2015 147S"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0047|cit48","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4088\/JCP.14m08986","article-title":"A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression","volume":"76","author":"Mischoulon","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0052|cit49","unstructured":"Rapaport MH Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16; Toronto, ON Canada] 2015 146S 7S"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0049|cit50","unstructured":"Rapaport MH Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00517036"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0050|cit51","unstructured":"Rapaport MH Nierenberg AA Schettler PJ Kinkead B Cardoos A Walker R Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study Molecular Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0051|cit52","unstructured":"Rapaport MH Schettler P Pace TW Kinkead B Nierenberg AA Mischoulon D Inflammation, depression and N-3 fatty acids: a case of personalized medicine abstract Neuropsychopharmacology [abstracts of the 52nd Annual Meeting of the American College of Neuropsychopharmacology, ACNP; 2013 Dec 8 - 12; Hollywood, FL United States] 2013 S353 S4"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0053|cit53","first-page":"3","article-title":"Omega-3 fatty acid effective as monotherapy for MDD","volume":"20","author":"Anonymous","year":"2009","journal-title":"Brown University Psychopharmacology Update"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0055|cit54","unstructured":"Mischoulon D Ethyl eicosapentanoic acid (Ethyl-EPA) for treating major depression ClinicalTrials.gov\/show\/NCT00096798"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0054|cit55","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4088\/JCP.08m04603","article-title":"A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder [NCT00096798]","volume":"70","author":"Mischoulon","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004692.pub4-BIB0057|cit57","first-page":"149","article-title":"Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance","volume":"5","author":"Nemets","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004692.pub4-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S0924-977X(02)80141-9","article-title":"Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance","volume":"12","author":"Stahl","year":"2002","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0060|cit59","unstructured":"Park Y Omega-3 index as a risk factor for depression in Korean and effect of Omega-3 fatty acids on Korean patients with depression [KCT0001206] cris.nih.go.kr\/cris\/en\/search\/search_result_st01.jsp?seq=4315"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub4-BIB0059|cit60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000377640","article-title":"Supplementation of n-3 polyunsaturated fatty acids for major depressive disorder: A randomized, double-blind, 12-week, placebo-controlled trial in Korea","volume":"66","author":"Park","year":"2015","journal-title":"Annals of Nutrition & Metabolism"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub4-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub4-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub4-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2891-11-82","article-title":"Comparison between the AA\/EPA ratio in depressed and non depressed elderly females: Omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters","volume":"11","author":"Rizzo","year":"2012","journal-title":"Nutrition Journal"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.2010.10719817","article-title":"Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: A double-blind, placebo-controlled, randomized clinical trial","volume":"29","author":"Rondanelli","year":"2010","journal-title":"Journal of the American College of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12603-011-0011-y","article-title":"Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life","volume":"15","author":"Rondanelli","year":"2011","journal-title":"Journal of Nutrition, Health & Aging"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0067|cit67","first-page":"22","article-title":"Adjunctive fish oil for depression","volume":"29","author":"Anonymous","year":"2005","journal-title":"Nurses' Drug Alert"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.plefa.2004.11.004","article-title":"Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression","volume":"72","author":"Silvers","year":"2005","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.euroneuro.2003.10.001","article-title":"Corrigendum to \"Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial\" [Eur Neuropsychopharmacol. 13 (2003) 267-271]","volume":"14","author":"Su","year":"2004","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0071|cit71","unstructured":"Clayton A Study of supplementation of antidepressants with fish oil to improve time to clinical response (SADFAT) ClinicalTrials.gov\/show\/NCT00963196"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0072|cit72","unstructured":"EUCTR2006-004949-41-IT Randomized double-blind study to evaluate the adjuvant effect of polyunsaturated fatty acids omega-3 in therapy with SSRI paroxetine mesylate in unipolar mood depression and recurrent depression www.ClinicalTrialsregister.eu\/ctr-search\/trial\/2006-004949-41\/IT"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0073|cit73","first-page":"S75","article-title":"A comparative study of addition therapy of choline alfoscerate and omega 3 fatty acid in older depressed patients with or without executive dysfunction","volume":"25","author":"Kwak","year":"2014","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0074|cit74","unstructured":"Lima L A randomised study on the antidepressive effect of fluoxetine and folic acid, as possible augmenter, and the SYNThesis of serotonin (5-HT) in lymphocytes prior and after treatment isrctn.org\/ISRCTN06123818"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0075|cit75","unstructured":"Murck H A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of Lax-101 (ethyl eicosapentaenoate) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy National Research Register 2004"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0076|cit76","unstructured":"Naqvi S Treating adolescent depression with fish oils ClinicalTrials.gov\/show\/NCT00658476"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0077|cit77","unstructured":"NCT00816322 The effect of fish oil in major depressive disorder ClinicalTrials.gov\/show\/NCT00816322"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0078|cit78","unstructured":"Rees AM Parker GB Owen C A study of omega-3 as a treatment for major depression ClinicalTrials.gov\/show\/NCT00238758"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0079|cit79","first-page":"A52","article-title":"Omega-3 polyunsaturated fatty acids as a treatment for major depression","volume":"39 Suppl 2","author":"Rees","year":"2005","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0080|cit80","unstructured":"Shinto L Fish oil for the treatment of depression in patients with multiple sclerosis ClinicalTrials.gov\/show\/NCT00122954"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0081|cit81","unstructured":"Su KP The effect of fish oil in major depressive disorder ClinicalTrials.gov\/show\/NCT01371383"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0082|cit82","unstructured":"Amminger GP Rice S Youth Depression Alleviation: a randomised controlled trial of omega-3 fatty acids (fish oil) for major depressive disorder in young people (YoDA-F) www.anzctr.org.au\/ACTRN12613001352796.aspx"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0083|cit83","unstructured":"Rice SM Hickie IB Yung AR Mackinnon A Berk M Davey C Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial Early Intervention in Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0084|cit84","unstructured":"Carney RM Omega-3 for depression and other cardiac risk factors - 2 ClinicalTrials.gov\/show\/NCT02021669"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0085|cit85","unstructured":"Gabbay V Omega-3 fatty acids in adolescent depression ClinicalTrials.gov\/show\/NCT00312897"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0086|cit86","unstructured":"Gabbay V The role of omega-3 fatty acids In adolescent depression ClinicalTrials.gov\/show\/NCT00962598"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0087|cit87","unstructured":"Howe P Fish oil treatment for depression in cardiovascular disease www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=82950"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0088|cit88","unstructured":"Jiang W Omega 3 for treatment of depression in patients with heart failure (OCEAN) ClinicalTrials.gov\/show\/NCT02057406"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0089|cit89","unstructured":"Kamath J Omega 3 FA supplements as augmentation in the treatment of depression ClinicalTrials.gov\/show\/NCT01803711"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0090|cit90","unstructured":"Khalili H Comparing efficacy of omega-3 and placebo in reducing Beck depression score in HIV\/AIDS patients www.irct.ir\/searchresult.php?id=3449&number=17"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0091|cit91","unstructured":"Lanct\u00f4t K Hermann N Treating depression in coronary artery disease with omega-3 fatty acids ClinicalTrials.gov\/show\/NCT00981383"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0092|cit92","unstructured":"Mostafavi S-A Akhondzadeh S Evaluating effects of omega-3 supplementation on weight and depression among overweight or obese women with depression compared to placebo www.irct.ir\/searchresult.php?id=16465&number=3"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0093|cit93","unstructured":"Nakano W Augmentation of omega-3 fatty acid with antidepressants for major depressive disorder: a double-blind, randomized controlled trial apps.who.int\/trialsearch\/Trial.aspx?TrialID=JPRN-UMIN000013525"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0094|cit94","unstructured":"Parker GB A study of omega-3 as an augmentor of antidepressant treatment for major depression ClinicalTrials.gov\/show\/NCT00289484"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0095|cit95","unstructured":"Parletta N Effects of a Mediterranean-style diet and fish oil supplements on mood and health www.anzctr.org.au\/ACTRN12614000438651.aspx"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0096|cit96","unstructured":"Piperoglou M Adjunctive natural low dose docosahexaenoic acid (DHA) omega-3 in a 16 week random double-blind placebo controlled (RDBPC) cross-over withdrawal study in a group of chronic, psychiatric out-patients with anxiety and mood disorders www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=365804"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0097|cit97","unstructured":"Smith D An 8 week randomised, double-blind, placebo controlled trial investigating the role of adjunctive bioactive lipids specifically; docosahexaenoic acid (DHA) versus eicosapentaenoic acid (EPA) in major depressive disorder - with a 6 week open label extension of DHA in patients aged 18 - 65 years www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000710022"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0098|cit98","unstructured":"Tayama J Omega-3 polyunsaturated fatty acids and psychological interventions for workers with mild to moderate depression: a randomized controlled trial www.umin.ac.jp\/ctr\/index.htm"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0099|cit99","unstructured":"Yao JK Coronary artery disease (CAD) risk in schizophrenia: effect of omega-3 fatty acid supplementation ClinicalTrials.gov\/show\/NCT00167310"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0100|cit100","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th Edition","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub4-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ajcn\/84.6.1308","article-title":"Effects of n3 long chain polyunsaturated fatty acids on depressed mood: systematic review of published trials","volume":"84","author":"Appleton","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00127-006-0142-3","article-title":"Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?","volume":"42","author":"Appleton","year":"2007","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.plefa.2008.04.009","article-title":"No clear evidence of an associations between plasma concentrations of n-3 long chain polyunsaturated fatty acids and depressed mood in a non-clinical population","volume":"78","author":"Appleton","year":"2008","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0954422408998620","article-title":"Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials","volume":"21","author":"Appleton","year":"2008","journal-title":"Nutrition Research Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3945\/ajcn.2009.28313","article-title":"Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood","volume":"91","author":"Appleton","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0106|cit106","volume-title":"Beck Depression Inventory Manual","author":"Beck","year":"1987"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/mp.2011.100","article-title":"Omega-3 fatty acids for the treatment of depression: Systematic review and meta-analysis","volume":"17","author":"Bloch","year":"2012","journal-title":"Molecular Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0108|cit108","volume-title":"BNF Briefing paper: n-3 fatty acids and health","author":"British Nutrition Foundation","year":"1999"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub4-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2005.10.009","article-title":"Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression","volume":"90","author":"Browne","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11745-003-1068-y","article-title":"n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcn\/63.1.116","article-title":"The effect on human tumor necrosis factor alpha and interleukin 1B production of diets enriched in n-3 fatty acids from vegetable oil or fish oil","volume":"63","author":"Caughey","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4-5","key":"10.1002\/14651858.CD004692.pub4-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.plefa.2006.07.005","article-title":"Omega-3 fatty acids and monoamine neurotransmission","volume":"75","author":"Chalon","year":"2006","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00005053-199805000-00007","article-title":"Use of the Center for Epidemiological Studies Depression (CES-D) scale in Korea","volume":"186","author":"Cho","year":"1998","journal-title":"J Nerv Ment Dis"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub4-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/jn\/129.11.2088","article-title":"Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula fed piglets","volume":"129","author":"Presa Owens","year":"1999","journal-title":"Journal of Nutrition"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","article-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jn\/124.12.2466","article-title":"Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats","volume":"124","author":"Delion","year":"1994","journal-title":"Journal of Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1046\/j.1471-4159.1996.66041582.x","article-title":"Alpha-linolenic acid dietary deficiency alters age related changes in dopaminergic and serotonergic neurotransmission in the rat frontal cortex","volume":"66","author":"Delion","year":"1996","journal-title":"Journal of Neurochemistry"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub4-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006795.pub3","article-title":"Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression","author":"Dennis","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub4-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1176\/ajp.150.8.1246","article-title":"Three concommitants: personality disorders, psychiatric severity, and outcome of dynamic psychotherapy of major depression","volume":"150","author":"Diguer","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0120|cit120","first-page":"170","article-title":"The psychological general well-being (PGWB) index","volume-title":"Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies","author":"Dupuy","year":"1984"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"s142","DOI":"10.1042\/bst026s142","article-title":"Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients","volume":"26","author":"Edwards","year":"1998","journal-title":"Biochemical Society Transactions"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/9780470693926.ch2","article-title":"Principles of and procedures for systematic reviews","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Egger","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0009-3084(90)90063-W","article-title":"A comparison of the effects of linolenic acid (18:3 omega 3) and docosahexaenoic (22:6 omega 3) acids on phospholipid bilayers","volume":"54","author":"Ehringer","year":"1990","journal-title":"Chemistry and Physics of Lipids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0124|cit124","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Min-mental state\": a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-859X-12-26","article-title":"No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis","volume":"12","author":"Fountoulakis","year":"2013","journal-title":"Annals of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.2009.1943","article-title":"Antidepressant drug effects and depression severity: a patient-level meta-analysis","volume":"303","author":"Fournier","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1192\/bjp.bp.105.019562","article-title":"Lipids and essential fatty acids in patients presenting with self-harm","volume":"190","author":"Garland","year":"2007","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0131|cit131","volume-title":"National Diet and Nutritional Survey of British Adults","author":"Gregory","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PloS One"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0133|cit133","volume-title":"Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, revised","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Canadian Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1176\/appi.ajp.161.3.567","article-title":"Is dietary intake of omega-3 fatty acids associated with depression?","volume":"161","author":"Hakkarainen","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.nut.2004.07.020","article-title":"Effects of w-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo controlled, double blind trial","volume":"21","author":"Hamazaki","year":"2005","journal-title":"Nutrition"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9110","key":"10.1002\/14651858.CD004692.pub4-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression","volume":"351","author":"Hibbeln","year":"1998","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub4-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD004692.pub4-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0141|cit141","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub4-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1176\/ajp.161.10.1922","article-title":"Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder","volume":"161","author":"Hirashima","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD004692.pub4-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"343s","DOI":"10.1093\/ajcn\/71.1.343s","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub4-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder","volume":"60","author":"Keck","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Medicine"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub4-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","article-title":"A meta-analytic review of double-blind, placebo-controlled trials of anti-depressant efficacy of omega-3 fatty acids","volume":"68","author":"Lin","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mp.2012.111","article-title":"Are omega-3 fatty acids anti-depressants or just mood-improving agents?","volume":"17","author":"Lin","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub4-BIB0149|cit149","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000448.pub3","article-title":"St John's wort for major depression","author":"Linde","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ajcn\/62.3.572","article-title":"Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters: The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"62","author":"Ma","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/plef.2002.0435","article-title":"Depression and adipose essential polyunsaturated fatty acids","volume":"67","author":"Mamalakis","year":"2002","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.plefa.2004.04.002","article-title":"Depression and adipose polyunsaturated fatty acids in an adolescent group","volume":"71","author":"Mamalakis","year":"2004","journal-title":"Prostaglandins, Leukotriens and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pbb.2006.10.008","article-title":"Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents","volume":"85","author":"Mamalakis","year":"2006","journal-title":"Pharmacology, Biochemistry and Behavior"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0154|cit154","first-page":"188","article-title":"EPA but not DHA appears to be responsible for the efficacy of omega-3 LC-PUFA supplementation in depression: Evidence from an updated meta-analysis of randomized controlled trials","volume":"18","author":"Martins","year":"2011","journal-title":"OCL - Oleagineux Corps Gras Lipides"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0155|cit155","first-page":"146S","article-title":"Omega-3 fatty acid deficiency decreases dopamine D2 receptor binding and increases serotonin 5-HT2A receptor binding in the adult rat prefrontal cortex","volume":"59","author":"McNamara","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub4-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009104.pub2","article-title":"Dietary supplements for preventing postnatal depression","author":"Miller","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1017\/S0033291706008701","article-title":"Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study","volume":"36","author":"Miyake","year":"2006","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0159|cit159","volume-title":"Depression: Management of Depression in Primary and Secondary Care","author":"National Institute for Clinical Excellence","year":"2004"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross-national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub4-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1176\/ajp.2006.163.6.969","article-title":"Omega-3 fatty acids and mood disorders","volume":"163","author":"Parker","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1192\/bjp.184.5.404","article-title":"International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis","volume":"184","author":"Peet","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(02)00427-6","article-title":"Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients","volume":"167","author":"Rallidis","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0165|cit165","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0166|cit166","article-title":"Hamilton Depression Inventory","volume-title":"Psychological Assessment Resources","author":"Reynolds","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub4-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0007114507801097","article-title":"No effect of n-3 long chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomized controlled trial","volume":"99","author":"Rogers","year":"2008","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-6-21","article-title":"Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?","volume":"6","author":"Ross","year":"2007","journal-title":"Lipids in Health and Disease"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1079\/NRR200497","article-title":"The impact of long chain n-3 polyunsaturated fatty acids on human health","volume":"18","author":"Ruxton","year":"2005","journal-title":"Nutrition Research Reviews"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1037\/0022-3514.69.4.719","article-title":"The structure of psychological well-being revisited","volume":"69","author":"Ryff","year":"1995","journal-title":"J Pers Soc Psychol"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3177\/jnsv.45.655","article-title":"The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double blind placebo controlled study","volume":"45","author":"Sawazaki","year":"1999","journal-title":"Journal of Nutritional Science and Vitaminology"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1079\/PHN2001308","article-title":"Fish consumption and self-reported physical and mental health status","volume":"5","author":"Silvers","year":"2002","journal-title":"Public Health Nutrition"},{"issue":"5-6","key":"10.1002\/14651858.CD004692.pub4-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0952-3278(99)80023-4","article-title":"Evoluntionary aspects of omega-3 fatty acids in the food supply","volume":"60","author":"Simopoulos","year":"1999","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5251\/ajfn.2011.1.1.14.27","article-title":"Essential fatty acids and mood: a systematic review of observational studies","volume":"1","author":"Smith","year":"2011","journal-title":"American Journal of Food and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0175|cit175","first-page":"57","article-title":"The role of omega-3 fatty acids in mood disorders","volume":"9","author":"Stahl","year":"2008","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/9780470693926.ch11","article-title":"Investigating and dealing with publication and other biases","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Sterne","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega-3 fatty acids in bipolar disorder - a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub4-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4088\/JCP.10m06634","article-title":"Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression","volume":"72","author":"Sublette","year":"2011","journal-title":"Journal of Clinical Psychiatry Diseases of the Nervous System"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub4-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-4328(01)00392-8","article-title":"Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat","volume":"131","author":"Takeuchi","year":"2002","journal-title":"Behavioral Brain Research"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub4-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpsyc.58.5.512","article-title":"Fish consumption, depression, and suicidality in a general population","volume":"58","author":"Tanskanen","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub4-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006875010120","article-title":"The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets","volume":"166","author":"Tappia","year":"1997","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"01286","DOI":"10.1002\/mds.20556","article-title":"Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation","volume":"20","author":"Taylor","year":"2005","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomology, clinician rating (IDS-C) and self report (IDS-SR), and the Quick Inventory of Depressive Symptomology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders; a psychometric evaluation.","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychological Medical"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0185|cit185","volume-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"10.1002\/14651858.CD004692.pub4-BIB0186|cit186","unstructured":"World Health Organization Global Burden of Disease www.who.int\/healthinfo\/global_burden_disease\/gbd\/en\/index.html"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2190\/U1B0-NKWC-568V-4MAK","article-title":"The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia","volume":"34","author":"Williams","year":"2004","journal-title":"International Journal of Psychiatry in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub4-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plefa.2004.03.011","article-title":"Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia","volume":"71","author":"Yao","year":"2004","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub4-BIB0190|cit190","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004692.pub2","article-title":"Omega 3 fatty acids for depression","author":"Silvers","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004692.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD004692.pub4\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T09:01:48Z","timestamp":1653469308000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004692.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,4]]},"references-count":190,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004692.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD004692.pub5","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,4]]}}}